| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.32 | 0.03 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |